Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)

Benjamin Rolles, Jan Philipp Bewersdorf, Tariq Kewan, Ondrej Blaha, Jessica M. Stempel, Luca Lanino, Najla H. Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Geoffrey L. Uy, Samuel Urrutia, Hetty E. Carraway, Pinkal Desai, Elizabeth A. Griffiths, Eytan M. Stein, Andrew M. Brunner, Christine McMahon, Rory M. Shallis, Joshua F. Zeidner, Michael R. Savona, Shougat Barua, Namrata Sonia Chandhok, Constantine Logothetis, Aram Bidikian, Ted M. Getz, Gail J. Roboz, Eunice S. Wang, Amyah C. Harris, Maria L. Amaya, Hayley Hawkins, Somedeb Ball, Justin Grenet, Parisa Abedi, Shai Shimony, R. Coleman Lindsley, Zhuoer Xie, Yazan F. Madanat, Yasmin Abaza, Talha Badar, Torsten Haferlach, Jaroslaw P. Maciejewski, David Sallman, Anoop Enjeti, Kamal Al‐Rabi, Khalid Halahleh, Devendra Hiwase, Maria Diez‐Campelo, David Valcarcel, Claudia Haferlach, Lisa Pleyer, Ioannis Kotsianidis, Vasiliki Pappa, Valeria Santini, Angela Consagra, Aref Al‐Kali, Seishi Ogawa, Yasuhito Nannya, Matteo Giovanni Della Porta, Rami S. Komrokji, Amer M. Zeidan, Maximilian Stahl

Open source

DOI
10.1002/ajh.70474
Published
2026-08-27
Container
American Journal of Hematology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ajh.70474,
  title = {Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)},
  author = {Benjamin Rolles and Jan Philipp Bewersdorf and Tariq Kewan and Ondrej Blaha and Jessica M. Stempel and Luca Lanino and Najla H. Al Ali and Amy E. DeZern and Mikkael A. Sekeres and Geoffrey L. Uy and Samuel Urrutia and Hetty E. Carraway and Pinkal Desai and Elizabeth A. Griffiths and Eytan M. Stein and Andrew M. Brunner and Christine McMahon and Rory M. Shallis and Joshua F. Zeidner and Michael R. Savona and Shougat Barua and Namrata Sonia Chandhok and Constantine Logothetis and Aram Bidikian and Ted M. Getz and Gail J. Roboz and Eunice S. Wang and Amyah C. Harris and Maria L. Amaya and Hayley Hawkins and Somedeb Ball and Justin Grenet and Parisa Abedi and Shai Shimony and R. Coleman Lindsley and Zhuoer Xie and Yazan F. Madanat and Yasmin Abaza and Talha Badar and Torsten Haferlach and Jaroslaw P. Maciejewski and David Sallman and Anoop Enjeti and Kamal Al‐Rabi and Khalid Halahleh and Devendra Hiwase and Maria Diez‐Campelo and David Valcarcel and Claudia Haferlach and Lisa Pleyer and Ioannis Kotsianidis and Vasiliki Pappa and Valeria Santini and Angela Consagra and Aref Al‐Kali and Seishi Ogawa and Yasuhito Nannya and Matteo Giovanni Della Porta and Rami S. Komrokji and Amer M. Zeidan and Maximilian Stahl},
  year = {2026},
  journal = {American Journal of Hematology},
  doi = {10.1002/ajh.70474},
  url = {https://doi.org/10.1002/ajh.70474}
}

RIS

TY  - JOUR
TI  - Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)
AU  - Benjamin Rolles
AU  - Jan Philipp Bewersdorf
AU  - Tariq Kewan
AU  - Ondrej Blaha
AU  - Jessica M. Stempel
AU  - Luca Lanino
AU  - Najla H. Al Ali
AU  - Amy E. DeZern
AU  - Mikkael A. Sekeres
AU  - Geoffrey L. Uy
AU  - Samuel Urrutia
AU  - Hetty E. Carraway
AU  - Pinkal Desai
AU  - Elizabeth A. Griffiths
AU  - Eytan M. Stein
AU  - Andrew M. Brunner
AU  - Christine McMahon
AU  - Rory M. Shallis
AU  - Joshua F. Zeidner
AU  - Michael R. Savona
AU  - Shougat Barua
AU  - Namrata Sonia Chandhok
AU  - Constantine Logothetis
AU  - Aram Bidikian
AU  - Ted M. Getz
AU  - Gail J. Roboz
AU  - Eunice S. Wang
AU  - Amyah C. Harris
AU  - Maria L. Amaya
AU  - Hayley Hawkins
AU  - Somedeb Ball
AU  - Justin Grenet
AU  - Parisa Abedi
AU  - Shai Shimony
AU  - R. Coleman Lindsley
AU  - Zhuoer Xie
AU  - Yazan F. Madanat
AU  - Yasmin Abaza
AU  - Talha Badar
AU  - Torsten Haferlach
AU  - Jaroslaw P. Maciejewski
AU  - David Sallman
AU  - Anoop Enjeti
AU  - Kamal Al‐Rabi
AU  - Khalid Halahleh
AU  - Devendra Hiwase
AU  - Maria Diez‐Campelo
AU  - David Valcarcel
AU  - Claudia Haferlach
AU  - Lisa Pleyer
AU  - Ioannis Kotsianidis
AU  - Vasiliki Pappa
AU  - Valeria Santini
AU  - Angela Consagra
AU  - Aref Al‐Kali
AU  - Seishi Ogawa
AU  - Yasuhito Nannya
AU  - Matteo Giovanni Della Porta
AU  - Rami S. Komrokji
AU  - Amer M. Zeidan
AU  - Maximilian Stahl
PY  - 2026
JO  - American Journal of Hematology
DO  - 10.1002/ajh.70474
UR  - https://doi.org/10.1002/ajh.70474
ER  - 

APA

Rolles, B., Bewersdorf, J. P., Kewan, T., Blaha, O., Stempel, J. M., Lanino, L., Ali, N. H. A., DeZern, A. E., Sekeres, M. A., Uy, G. L., Urrutia, S., Carraway, H. E., Desai, P., Griffiths, E. A., Stein, E. M., Brunner, A. M., McMahon, C., Shallis, R. M., Zeidner, J. F., Savona, M. R., Barua, S., Chandhok, N. S., Logothetis, C., Bidikian, A., Getz, T. M., Roboz, G. J., Wang, E. S., Harris, A. C., Amaya, M. L., Hawkins, H., Ball, S., Grenet, J., Abedi, P., Shimony, S., Lindsley, R. C., Xie, Z., Madanat, Y. F., Abaza, Y., Badar, T., Haferlach, T., Maciejewski, J. P., Sallman, D., Enjeti, A., Al‐Rabi, K., Halahleh, K., Hiwase, D., Diez‐Campelo, M., Valcarcel, D., Haferlach, C., Pleyer, L., Kotsianidis, I., Pappa, V., Santini, V., Consagra, A., Al‐Kali, A., Ogawa, S., Nannya, Y., Porta, M. G. D., Komrokji, R. S., Zeidan, A. M., & Stahl, M. (2026). Impact of Response to Hypomethylating Agent‐Based Therapy on Survival Outcomes in the Context of Baseline Clinical‐Molecular Risk and Transplant Status in Patients With Higher‐Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS). American Journal of Hematology. https://doi.org/10.1002/ajh.70474

Source records